"Keratin-20" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type I keratin expressed predominately in gastrointestinal epithelia, MERKEL CELLS, and the TASTE BUDS of the oral mucosa.
| Descriptor ID |
D053554
|
| MeSH Number(s) |
D05.750.078.593.450.300.950 D12.776.220.475.450.300.950 D12.776.860.607.300.950
|
| Concept/Terms |
Keratin-20- Keratin-20
- Keratin 20
- Cytokeratin 20
- Cytokeratin-20
|
Below are MeSH descriptors whose meaning is more general than "Keratin-20".
Below are MeSH descriptors whose meaning is more specific than "Keratin-20".
This graph shows the total number of publications written about "Keratin-20" by people in this website by year, and whether "Keratin-20" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Keratin-20" by people in Profiles.
-
Kato S, Koshino A, Lasota J, Komura M, Wang C, Ebi M, Ogasawara N, Kojima K, Tsuzuki T, Kasai K, Takahashi S, Miettinen M, Kasugai K, Inaguma S. Use of SATB2 and CDX2 Immunohistochemistry to Characterize and Diagnose Colorectal Cancer. Appl Immunohistochem Mol Morphol. 2024 09 01; 32(8):362-370.
-
Lombardo KA, Murati Amador B, Parimi V, Hoffman-Censits J, Choi W, Hahn NM, Kates M, Bivalacqua TJ, McConkey D, Hoque MO, Matoso A. Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome. Appl Immunohistochem Mol Morphol. 2021 02 01; 29(2):127-135.
-
Laschinger ME, Naga L, Gaspari AA. Cutaneous metastases of pancreatic neuroendocrine carcinoma. G Ital Dermatol Venereol. 2018 Oct; 153(5):722-724.
-
Sandilands A, Smith FJ, Lunny DP, Campbell LE, Davidson KM, MacCallum SF, Corden LD, Christie L, Fleming S, Lane EB, McLean WH. Generation and characterisation of keratin 7 (K7) knockout mice. PLoS One. 2013; 8(5):e64404.
-
Knoepp SM, Hookim K, Placido J, Fields KL, Roh MH. The application of immunocytochemistry to cytologic direct smears of metastatic merkel cell carcinoma. Diagn Cytopathol. 2013 Aug; 41(8):729-33.
-
Porjazova E, Zaprjanov Z, Batashki I, Markova D, Milchev N. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2]. Akush Ginekol (Sofiia). 2009; 48(2):7-12.
-
Weaver EJ, McCue PA, Bagley DH, Kovatich AJ, Bibbo M. Expression of cytokeratin 20 and CD44 protein in upper urinary tract transitional cell carcinoma: cytologic-histologic correlation. Anal Quant Cytol Histol. 2001 Oct; 23(5):339-44.
-
Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995 May; 8(4):384-8.